Skip to Main Content
Try STAT+ TODAY
Trending:
Health
Coronavirus
Biotech
First Opinion
Subscribe Now To access exclusive content, subscribe to STAT+
View Latest View the latest STAT+ stories
Biotech
STAT+

Biotech venture capitalists have more money than ever to invest. What could possibly go wrong?

  • Kate Sheridan

By Kate Sheridan April 7, 2021

Reprints
money pile
Adobe

There’s more money sloshing around in biotech than ever before.

Over the past year, several trends have converged to create a historic financing environment for startups, full of what industry insiders call “dry powder.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

About the Author Reprints

Kate Sheridan

Kate Sheridan

Research Reporter

Kate collects and analyzes documents, data, and other information for biotech, health tech, science, and politics stories.

Tags

Inside the fall of star MIT scientist David Sabatini
Inside the fall of star MIT scientist David Sabatini
Pfizer is scolded by a U.K. trade group for…
Pfizer is scolded by a U.K. trade group for remarks its CEO made about vaccination
Two new studies paint encouraging picture of Covid-19 vaccine’s…
Two new studies paint encouraging picture of Covid-19 vaccine’s performance
Inside the fall of star MIT scientist David Sabatini
Inside the fall of star MIT scientist David Sabatini
Federal panel approves plans to safeguard lab-made virus research
Federal panel approves plans to safeguard lab-made virus research
After bullying allegations, Eric Lander will return to run…
After bullying allegations, Eric Lander will return to run a lab at the Broad Institute

Recommended Stories